Objectives:

Achievement of patients’ preferred place of death is recognized as a component of a good death. This study aimed to investigate the symptom burden in advanced cancer patients, achievement of their place of death preferences and factors associated with home death.

Methods:

In this retrospective review of 287 patient deaths, we examined patients’ symptom prevalence, preferred and actual place of death and achievement of their place of death preferences using descriptive statistics. Associations between patient factors, home death preference and actual home death were further analyzed using multivariate logistic regression.

Results:

The most prevalent symptoms were weakness, pain and poor appetite, with a mean of 5.77(SD: 2.37) symptoms per patient. The median interval from palliative care referral to death was 21 (IQR: 74) days. Of the 253 patients with documented place of death preference, 132 (52.1%) preferred home death, 111(43.9%) preferred hospital death, 1 (0.4%) preferred to die at a temple and 9(3.6%) expressed no preference. Overall, 221 of 241(91.7%) patients with known actual place of death achieved their preference. Older patients were more likely to prefer home death (OR 1.021; 95% CI 1.004-1.039, p = 0.018) and die at home (OR 1.023; 95% CI 1.005-1.041, p = 0.014). Gender, marital status, cancer diagnosis and symptoms were not associated with preference for or actual home death.

Conclusion:

Despite a high symptom burden, most patients preferred and achieved a home death. Late palliative care referral and difficult symptom management contributed to failure to fulfill home death preference. Preference for home death should be considered when managing terminally ill geriatric patients.

1. Department of Health. End of Life Care Strategy—Promoting High Quality Care of All Adults at the End of Life. Department of Health; 2008.
2. Meier EA, Gallegos JV, Thomas LP, Depp CA, Irwin SA, Jeste DV. Defining a good death (successful dying): literature review and a call for research and public dialogue. Am J Geriatr Psychiatry. 2016;24(4):261-271.
3. Cameron J, Parkes CM. Terminal care: evaluation of effects on surviving family of care before and after bereavement. Postgrad Med J. 1983;59(688):73-78.
4. Brogaard T, Neergaard MA, Sokolowski I, Olesen F, Jensen AB. Congruence between preferred and actual place of care and death among Danish cancer patients. Palliat Med. 2013;27(2): 155-164.
5. Hunt KJ, Shlomo N, Addington-Hall J. End-of-life care and achieving preferences for place of death in England: results of a population-based survey using the VOICES-SF questionnaire. Palliat Med. 2014;28(5):412-421.
6. Arnold E, Finucane AM, Oxenham D. Preferred place of death for patients referred to a specialist palliative care service. BMJ Support Palliat Care. 2015;5(3):294-296.
7. Gu X, Cheng W, Cheng M, Liu M, Zhang Z. The preference of place of death and its predictors among terminally ill patients with cancer and their caregivers in China. Am J Hosp Palliat Care. 2015;32(8):835-840.
8. Natsume M, Watanabe K, Matsumoto S, et al. Factors influencing cancer patients’ choice of end-of-life care place. J Palliat Med. 2018;21(6):751-765.
9. Blanchard CL, Ayeni O, O’Neil DS, et al. A prospective cohort study of factors associated with place of death among patients with late-stage cancer in Southern Africa. J Pain Symptom Manage. 2019;57(5):923-932.
10. Alsirafy SA, Hammad AM, Ibrahim NY, Farag DE, Zaki O. Preferred place of death for patients with incurable cancer and their family caregivers in Egypt. Am J Hosp Palliat Care. 2019;36(5): 423-428.
11. Rasch-Westin M, Helde-Frankling M, Bjo¨ rkhem-Bergman L. Death at home: predictive factors in a medical home care unit. BMJ Support Palliat Care. 2019. doi:10.1136/bmjspcare-2019- 001932
12. Gomes B, Calanzani N, Koffman J, Higginson IJ. Is dying in hospital better than home in incurable cancer and what factors influence this? A population-based study. BMC Med. 2015;13:235.
13. Howell DA, Wang HI, Roman E, et al. Preferred and actual place of death in haematological malignancy. BMJ Support Palliat Care. 2017;7(2):150-157.
14. Teunissen SC,Wesker W, Kruitwagen C, de HaesHC, Voest EE, de Graeff A. Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manage. 2007;34(1):94-104.
15. van den Beuken-van Everdingen MH, Hochstenbach LM, Joosten EA, Tjan-Heijnen VC, Janssen DJ. Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. J Pain Symptom Manage. 2016;51(6):1070-1090.e9.
16. Laugsand EA, Jakobsen G, Kaasa S, Klepstad P. Inadequate symptom control in advanced cancer patients across Europe. Support Care Cancer. 2011;19(12):2005-2014.
17. Linge-Dahl L, Vranken M, Juenger S, et al. Identification of challenges to the availability and accessibility of opioids in twelve European countries: conclusions from two ATOME sixcountry workshops. J Palliat Med. 2015;18(12):1033-1039.
18. ACHEON Working Group; Kim YC, Ahn J S, et al. Current practices in cancer pain management in Asia: a survey of patients and physicians across 10 countries. Cancer Med. 2015;4(8): 1196-1204.
19. Ho JFV, Yaakup H, Low GSH, Wong SL, Tho LM, Tan SB. Morphine use for cancer pain: a strong analgesic used only at the end of life? A qualitative study on attitudes and perceptions of morphine in patients with advanced cancer and their caregivers. Palliat Med. 2020;34(5):619-629.
20. Horlait M, Chambaere K, Pardon K, Deliens L, Van Belle S. What are the barriers faced by medical oncologists in initiating discussion of palliative care? A qualitative study in Flanders, Belgium. Support Care Cancer. 2016;24(9):3873-3881.
21. Bannon F, Cairnduff V, Fitzpatrick D, Blaney J, Gomes B, Gavin A, Donnelly C. Insights into the factors associated with achieving the preference of home death in terminal cancer: a national population-based study. Palliat Support Care. 2018;16(6): 749-755.
22. Nilsson J, Blomberg C, Holgersson G, Carlsson T, Bergqvist M, Bergstro¨m S. End-of-life care: where do cancer patients want to die? A systematic review. Asia Pac J Clin Oncol. 2017;13(6): 356-364.
23. Turner V, Flemming K. Socioeconomic factors affecting access to preferred place of death: a qualitative evidence synthesis. Palliat Med. 2019;33(6):607-617.
24. Oxenham D, Finucane A, Arnold E, Russell P. Delivering preference for place of death in a specialist palliative care setting. BMJ Qual Improv Rep. 2013;2(1):u201375.w897.
25. Ali M, Capel M, Jones G, Gazi T. The importance of identifying preferred place of death. BMJ Support Palliat Care. 2019;9(1): 84-91.
26. Cai J, Zhang L, Guerriere D, Fan H, Coyte PC. What variables contribute to the achievement of a preferred home death for cancer patients in receipt of home-based palliative care in Canada? Cancer Nurs. 2021;44(3):214-222.
27. Kulkarni P, Kulkarni P, Anavkar V, Ghooi R. Preference of the place of death among people of Pune. Indian J Palliat Care. 2014; 20(2):101-106.
28. Murtagh FE, Ramsenthaler C, Firth A, et al. A brief, patient- and proxy-reported outcome measure in advanced illness: validity, reliability and responsiveness of the integrated palliative care outcome scale (IPOS). Palliat Med. 2019;33(8):1045-1057.
29. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424.
30. Laugsand EA, Sprangers MA, Bjordal K, Skorpen F, Kaasa S, Klepstad P. Health care providers underestimate symptom intensities of cancer patients: a multicenter European study. Health Qual Life Outcomes. 2010;8:104.
31. Xiao C, Polomano R, Bruner DW. Comparison between patientreported and clinician-observed symptoms in oncology. Cancer Nurs. 2013;36(6):E1-E16.
32. Yang SL, Woon YL, Teoh CCO, Leong CT, Lim RBL. Adult palliative care 2004-2030 population study: estimates and projections in Malaysia. BMJ Support Palliat Care. 2020. doi:10.1136/ bmjspcare-2020-002283
33. Yeung NY. Expectation of the place of care and place of death of terminal cancer patients in Hong Kong: a hospital based crosssectional questionnaire survey. Ann Palliat Med. 2020;9(6): 4534-4548.
34. Bell CL, Somogyi-Zalud E, Masaki KH. Factors associated with congruence between preferred and actual place of death. J Pain Symptom Manage. 2010;39(3):591-604.
35. Chapple A, Evans J, McPherson A, Payne S. Patients with pancreatic cancer and relatives talk about preferred place of death and what influenced their preferences: a qualitative study. BMJ Support Palliat Care. 2011;1(3):291-295.
36. Fukui S, Fujita J, Tsujimura M, Sumikawa Y, Hayashi Y, Fukui N. Late referrals to home palliative care service affecting death at home in advanced cancer patients in Japan: a nationwide survey. Ann Oncol. 2011;22(9):2113-2120.
37. Tan WS, Bajpai R, Ho AHY, Low CK, Car J. Retrospective cohort analysis of real-life decisions about end-of-life care preferences in a Southeast Asian country. BMJ Open. 2019; 9(2):e024662.
38. Tang ST. Meanings of dying at home for Chinese patients in Taiwan with terminal cancer: a literature review. Cancer Nurs. 2000;23(5):367-370.
39. Lou C, Lou K, Ridley J. Exploring the meaning of dignity at end of life for Chinese Canadians caregivers: a qualitative crosscultural study. Palliat Med. 2021;35(1):142-150.
40. Venkatasalu MR, Seymour JE, Arthur A. Dying at home: a qualitative study of the perspectives of older South Asians living in the United Kingdom. Palliat Med. 2014;28(3):264-272.
41. Boussarsar M, Bouchoucha S. Dying at home: cultural and religious preferences. Intensive Care Med. 2006;32(11):1917-1918.